Close

Incyte (INCY) Overvalued, Thinks Goldman Sachs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. IBM
8. V
9. KMB
10. MSFT


Go back to Incyte (INCY) Overvalued, Thinks Goldman Sachs
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 51.74 +0.09 (0.17%)
Previous Close $51.65    52 Week High $118.49 
Open $51.65    52 Week Low $55.00 
Day High $51.84    P/E N/A 
Day Low $51.14    EPS $-0.56 
Volume 1,564,434